Hot of the breath: Mortality as a primary end-point in IPF treatment trials: the best is the enemy of the good
Year: 2012
Type: editorial
Abstract: Comment in "Idiopathic pulmonary fibrosis: is all-cause mortality a practical and realistic end-point for clinical trials?" [Thorax. 2013]
Source: Thorax
Authors: Athol U Wells, Juergen Behr, Ulrich Costabel, Vincent Cottin, Venerino Poletti, Luca Richeldi, for the European IPF consensus group
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2117885404
